Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Etanercept

Uveitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Chakhalian M, et al. The clinical features of uveitis de-novo in juvenile idiopathic arthritis patients developed on biologic treatment. Pediatric Rheumatology 18 (Suppl. 2): 76 abstr. P275, 28 Oct 2020. Available from: URL: http://doi.org/10.1186/s12969-020-00470-5 [abstract] Chakhalian M, et al. The clinical features of uveitis de-novo in juvenile idiopathic arthritis patients developed on biologic treatment. Pediatric Rheumatology 18 (Suppl. 2): 76 abstr. P275, 28 Oct 2020. Available from: URL: http://​doi.​org/​10.​1186/​s12969-020-00470-5 [abstract]
Metadaten
Titel
Etanercept
Uveitis: 2 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-90328-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Immune-globulin

Case report

Crizotinib

Case report

Ranibizumab